These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9044302)

  • 1. Structure of advanced Maillard reaction products and their pathological role.
    Monnier VM; Nagaraj RH; Portero-Otin M; Glomb M; Elgawish AH; Sell DR; Friedlander MA
    Nephrol Dial Transplant; 1996; 11 Suppl 5():20-6. PubMed ID: 9044302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New biomarkers of Maillard reaction damage to proteins.
    Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
    Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.
    Henle T; Deppisch R; Beck W; Hergesell O; Hänsch GM; Ritz E
    Nephrol Dial Transplant; 1999 Aug; 14(8):1968-75. PubMed ID: 10462279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
    Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
    J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
    Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
    Smith MA; Taneda S; Richey PL; Miyata S; Yan SD; Stern D; Sayre LM; Monnier VM; Perry G
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5710-4. PubMed ID: 8202552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of a glucose-derived Maillard reaction product in the human lens.
    Nagaraj RH; Sady C
    FEBS Lett; 1996 Mar; 382(3):234-8. PubMed ID: 8605976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes.
    Nagaraj RH; Portero-Otin M; Monnier VM
    Arch Biochem Biophys; 1996 Jan; 325(2):152-8. PubMed ID: 8561492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen.
    Nagaraj RH; Kern TS; Sell DR; Fogarty J; Engerman RL; Monnier VM
    Diabetes; 1996 May; 45(5):587-94. PubMed ID: 8621008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of pentosidine and pyrraline in food and chemical models: formation, potential risks and determination.
    Li H; Yu SJ
    J Sci Food Agric; 2018 Jul; 98(9):3225-3233. PubMed ID: 29280151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?
    Zeier M; Schwenger V; Deppisch R; Haug U; Weigel K; Bahner U; Wanner C; Schneider H; Henle T; Ritz E
    Kidney Int; 2003 Jan; 63(1):298-305. PubMed ID: 12472796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrraline Formation Modulated by Sodium Chloride and Controlled by Encapsulation with Different Coating Materials in the Maillard Reaction.
    Liang Z; Chen X; Yang Z; Lai Y; Yang Y; Lei C; Zeng Y
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31717655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic protein glycation.
    Smith PR; Somani HH; Thornalley PJ; Benn J; Sonksen PH
    Clin Sci (Lond); 1993 Jan; 84(1):87-93. PubMed ID: 8382140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia.
    Monnier VM; Sell DR; Nagaraj RH; Miyata S; Grandhee S; Odetti P; Ibrahim SA
    Diabetes; 1992 Oct; 41 Suppl 2():36-41. PubMed ID: 1526333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of advanced glycation end products in human cataractous lenses.
    Franke S; Dawczynski J; Strobel J; Niwa T; Stahl P; Stein G
    J Cataract Refract Surg; 2003 May; 29(5):998-1004. PubMed ID: 12781289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage.
    Meng J; Sakata N; Takebayashi S; Asano T; Futata T; Nagai R; Ikeda K; Horiuchi S; Myint T; Taniguchi N
    Atherosclerosis; 1998 Feb; 136(2):355-65. PubMed ID: 9543107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary pyrraline as a biochemical marker of non-oxidative Maillard reactions in vivo.
    Portero-Otín M; Pamplona R; Bellmunt MJ; Bergua M; Nagaraj RH; Prat J
    Life Sci; 1997; 60(4-5):279-87. PubMed ID: 9010483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo.
    Portero-Otin M; Nagaraj RH; Monnier VM
    Biochim Biophys Acta; 1995 Feb; 1247(1):74-80. PubMed ID: 7873594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease.
    Friedlander MA; Wu YC; Schulak JA; Monnier VM; Hricik DE
    Am J Kidney Dis; 1995 Mar; 25(3):445-51. PubMed ID: 7872323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.